Canada helps importers, distributors prepare for initial GMP inspection
This article was originally published in SRA
Health Canada has developed a "pre-application package" to help companies involved in the importation, distribution or wholesale of drugs prepare for an initial good manufacturing practice inspection1.
You may also be interested in...
Sponsors of new and existing medicines in New Zealand will have to update their product labels within specified deadlines to include warning statements about certain allergens.
A draft EU guideline explains how disease registries can be used to supplement evidence in the pre-authorization phase and provide infrastructure for post-authorization evidence generation.
Companies are being encouraged to become “early adopters” of the EU Clinical Trials Information System when it goes live in December 2021.